New York, SiliconValley, India and Israel-based venture capital firm Canaan Partners has closed a $600m fund.
Supporters include existing and new limited partners.
Canaan IX, which brings total capital under management to $3.5bn, will enable the firm to continue to back innovative global companies in the technology and healthcare sectors. The firm will allocate approximately two-thirds of the fund to technology investments in digital media, consumer internet, enterprise, mobile and communications companies in the U.S., India and Israel. The other one-third is designated to healthcare investments in biopharmaceutical, medical device and healthcare infrastructure companies.
General partners in Canaan IX are Brent Ahrens, John Balen, Stephen Bloch, MD, Wende Hutton, Maha Ibrahim, Deepak Kamra, Warren Lee, Guy Russo and Izhar Shay; in addition, the fund is advised by Alok Mittal, Managing Director of Canaan India.